[go: up one dir, main page]

UA92498C2 - Cannabinoid active pharmaceutical ingredient for improved dosage forms - Google Patents

Cannabinoid active pharmaceutical ingredient for improved dosage forms

Info

Publication number
UA92498C2
UA92498C2 UAA200800554A UAA200800554A UA92498C2 UA 92498 C2 UA92498 C2 UA 92498C2 UA A200800554 A UAA200800554 A UA A200800554A UA A200800554 A UAA200800554 A UA A200800554A UA 92498 C2 UA92498 C2 UA 92498C2
Authority
UA
Ukraine
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
dosage forms
cannabinoid active
tetrahydrocannabinol
Prior art date
Application number
UAA200800554A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Роберт Дж. Куппер
Original Assignee
Евро-Селтик С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евро-Селтик С.А. filed Critical Евро-Селтик С.А.
Publication of UA92498C2 publication Critical patent/UA92498C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pharmaceutical compositions comprising the cannabinoid active pharmaceutical ingredient, crystalline trans-(±)-Δ-tetrahydrocannabinol, and formulations thereof are disclosed. The invention also relates to methods for treating or preventing a condition such as pain comprising administering to a patient in need thereof an effective amount of crystalline trans-(±)-Δ-tetrahydrocannabinol. In specific embodiments, the crystalline trans-(±)-Δ-tetrahydrocannabinol administered according to the methods for treating or preventing a condition such as pain can have a purity of at least about 98% based on the total weight of cannabinoids.
UAA200800554A 2005-06-16 2006-06-14 Cannabinoid active pharmaceutical ingredient for improved dosage forms UA92498C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69136105P 2005-06-16 2005-06-16

Publications (1)

Publication Number Publication Date
UA92498C2 true UA92498C2 (en) 2010-11-10

Family

ID=39548322

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200800554A UA92498C2 (en) 2005-06-16 2006-06-14 Cannabinoid active pharmaceutical ingredient for improved dosage forms

Country Status (4)

Country Link
CN (1) CN101198324B (en)
ES (1) ES2357250T3 (en)
UA (1) UA92498C2 (en)
ZA (1) ZA200709788B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758826B2 (en) * 2011-07-05 2014-06-24 Wet Inc. Cannabinoid receptor binding agents, compositions, and methods
CN105873566B (en) * 2013-10-29 2019-06-07 艾克制药有限公司 The purposes of compressed tablets containing Δ 9- tetrahydrocannabinol, its manufacturing method and such tablet in oral medication
CA3111682A1 (en) 2014-06-26 2015-12-30 Island Breeze Systems Ca, Llc Mdi related products and methods of use
EP3672587A4 (en) 2017-08-27 2021-05-19 Rhodes Technologies PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES
EP3784184A4 (en) * 2018-04-27 2022-05-11 Remy Biosciences, Inc. NEW MEDICAL DEVICES, DELIVERY VEHICLES AND THEIR MANUFACTURE
CN109970516A (en) * 2019-03-20 2019-07-05 栾云鹏 A kind of synthetic method of the cannabinoids substance of preparation of industrialization high-purity high-yield
CN111943813B (en) * 2019-05-17 2023-04-14 上海特化医药科技有限公司 Preparation method of cannabidiol compound
CN110200953B (en) * 2019-06-15 2022-02-08 汉义生物科技（北京）有限公司 Use of cannabinoids in the manufacture of a medicament for inhalation administration
CN113173857B (en) * 2021-03-09 2023-05-23 昆明理工大学 Cannabidiol derivative and preparation method and application thereof
CN113440508B (en) * 2021-07-27 2023-10-27 昆明理工大学 New application of cannabidiol derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US6509005B1 (en) * 1998-10-27 2003-01-21 Virginia Commonwealth University Δ9 Tetrahydrocannabinol (Δ9 THC) solution metered dose inhaler
CA2402020C (en) * 2000-03-09 2006-08-29 Gw Pharma Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
CN101198324A (en) 2008-06-11
CN101198324B (en) 2011-06-08
ES2357250T3 (en) 2011-04-20
ZA200709788B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
MY140576A (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
TW200633695A (en) Methods for purifying trans-(-)-Δ9-tetrahydrocannabinol and trans-(+)-Δ9-tetrahydrocannabinol
MXPA04004842A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2427227A1 (en) Lactam compound
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2004052847A3 (en) Tricyclic steroid hormone nuclear receptor modulators
PL373276A1 (en) Trans-epicutaneous administration form for treating restless leg syndrome
SE9901573D0 (en) New compounds
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
UA92498C2 (en) Cannabinoid active pharmaceutical ingredient for improved dosage forms
WO2006115770A3 (en) Orally disintegrating pharmaceutical tablet formulations of olanzapine
SE9901572D0 (en) New compounds
SI1893237T1 (en) Pharmaceutical composition comprising an organopolysiloxane elastomer and a solubilized active principle
SG146631A1 (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
MXPA04005033A (en) Pharmaceutical composition comprising a combination of metformin and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
TW200740440A (en) Novel combinations of medicaments for the treatment of respiratory diseases containing long-acting beta-agonists and at least one additional active ingredient
TW200515912A (en) Use of oxcarbazepine for the treatment of diabetic neuropathic pain and the improvement of sleep
CA2586664A1 (en) Isoxazolic derivative to relieve neuropathic pain
ES2173044A1 (en) Glycine, n-[n-l-gamma-glutamyl-3-(nitrosothio)-l-valyl] and use thereof
YU87302A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1